Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Centers (SAFFICIENT)

Stopped Given the recent FDA approval of the VARIPULSE platform in November 2024, J\&J MedTech and the PI have made the strategic decision to phase out SAFFICIENT IDE to focus on the post-approval study

Conditions

• Atrial Fibrillation

Interventions

• DEVICE: Catheter ablation using pulsed-field ablation (PFA) system

Sponsor

Texas Cardiac Arrhythmia Research Foundation